Never miss a story

Get subscribed to our newsletter


×
Some popular products for Indian skincare are Indigo Gel Cream, Indigo Spray Mist for Day skincare, Camellia Rich Ageing Cream and Camellia Seed Oil for night skincare. Flickr

A large population around the world is demanding organic or vegan beauty products and shoppers are now becoming more aware of how harmful chemicals can affect their skin.

Vegan beauty has become more and more popular in recent years as the wellness arena has expanded; it has pretty much crossed over to the mainstream. Lifestyle choices such as veganism and clean eating have opened more opportunities for essential and natural skincare products.


Follow us on Instagram for more updates!!

Eco-conscious consumers are increasingly making the shift from mass-produced to eco-friendly goods in order to reduce the harm caused to the environment and are switching to sustainable skincare products which also means contributing to protecting the environment.

South Korean beauty brand Jejuindi has introduced its whole range of organic products like Anti-Ageing Rich Cream Face Serums, Moisturisers/Spray, Face Mask Serum, Face Wash, Body/Face light Cream.


Skincare is of utmost importance and our tropical temperature, variations in humidity and pollution necessitates skincare. Flickr

With the onset of monsoon, skin care is of utmost importance and our tropical temperature, variations in humidity and pollution necessitates skincare. The natural plant-based brand features products which have more vitamins and minerals that the skin absorbs quickly. The products introduced in India are anti-bacterial, anti-aging and they soothe the skin in fluctuating climate.

Sanjay Singh, Country Head Jejuindi-India said, “Jejuindi-India is striving to bring in the best vegan and animal cruelty-free products for Indian consumers. Great Skin doesn’t happen by chance, so living up to their motto ‘Skin-Care First, Makeup Second’, the natural skin-care products are essential for your daily skincare routine. We are introducing pure natural essential skincare products range specially catered for the Indian beauty market. Over the last few years, the relations between India-South Korea relations have made great strides and taking advantage of the situation, Jejuindi may look at their own manufacturing unit in India in the near future.”

Also Read: Fashion Industry and It’s Way to Recovery

He adds further, “Having the Indian markets surveyed on various counts, Jejuindi-India is launching more suitable vegan products specially curated for the ‘Indian Skin tone’ and to fight the tropical weather. Also in today’s situation, the continuous use of sanitizer on hands is damaging the texture of the skin and disturbing PH balance. Using these products will provide the hand adequate moisturizer needed to keep it soft.”

Some popular products for Indian skincare are Indigo Gel Cream, Indigo Spray Mist for Day skincare, Camellia Rich Ageing Cream and Camellia Seed Oil for night skincare. Along with these, the brand has also launched its patented beauty products made from camellia flowers, indigo plant, Portulaca herbs, seaweed, and tangerines. (IANS)


Popular

Photo by Wikimedia Commons

Anti-viral drug Molnupiravir may emerge as the game changer in the fight against Covid-19.

Anti-viral drug Molnupiravir may emerge as the game-changer in the fight against Covid-19 as studies suggest it can reduce the risk of hospitalization or death in newly diagnosed patients, an expert says.

Distinguished cardiologist and health systems expert Dr. Krishna Reddy Nallamalla believes that Molnupiravir as an effective oral drug for the treatment of Covid-19 assumes significance as cases are still being reported despite vaccines, which are not as effective against the spread of the virus and have lower efficacy against certain variants.

Almost two years since the onset of the pandemic, the world has reported close to 250 million positive cases and 5 million deaths, while half a million cases are still being reported every day.

"We have face masks, vaccines, and steroids to fight the pandemic. We also have the expensive injectable antiviral drug Remedesivir and the monoclonal antibody cocktail for those who can afford these. Most of the oral drugs, including chloroquine, ivermectin, anti-HIV drugs, anti-hepatitis drugs.. did not stand the scrutiny of scientific studies. Some others had weak evidence to be of large-scale," said Dr. Krishna Reddy, who is also President of InOrder, a nonprofit institute working to strengthen systems to secure the health and Regional Director (South Asia) of global health non-profit, ACCESS Health International.

"Despite the development of Covid-19 vaccines in a record time period, the world continues to witness daily positive cases of half a million. While vaccines have been effective against moderate to severe illness, they have not been as effective against the spread of the virus. In addition, the efficacy is lower against certain new variants. Another growing concern has been the rapid decline in neutralizing antibodies within six months after the second dose necessitating the booster dose in people at high risk," he said.

He also pointed out that the inequity in access to vaccines has been glaring within and between countries.

On how Molnupiravir helps, Krishna Reddy said that the basic building blocks of coronavirus are ribonucleic acids (RNA), and their analogs can produce mutations that are lethal to the virus. While Remedesivir is an analog and is demonstrated to reduce hospital stay in moderately-ill Covid patients, it is expensive and has to be given through the intravenous route.

"Molnupiravir was earlier developed as an oral drug against influenza. It is also an analog of ribonucleic acids, similar to Remedesivir. In a preprint published in June, virus isolation was noted in 1.6 per cent of those patients receiving Molnupiravir compared to 16.7 per cent of those receiving placebo on day 3 and 0 per cent and 11.1 per cent respectively on day 5," Krishna Reddy said.

Merck and Ridgeback have announced on October 11, the submission of an emergency use authorization application to the US FDA for the treatment of mild to moderate cases (room air oxygen saturation more than 93 per cent at rest).

The submission is based on positive results from a planned interim analysis from the phase 3 MOVe-OUT clinical trial, which evaluated Molnupiravir in non-hospitalized adults with mild to moderate Covid illness who were at risk to progress to severe Covid requiring hospitalization.

In the interim analysis, there was a 50 per cent reduction in risk of hospitalization or death (7.3 per cent with drug vs 14.1 per cent with placebo) with Molnupiravir. Full results of the trial are awaited.

Merck has previously announced that it has entered into non-exclusive voluntary licensing agreements for Molnupiravir with six established Indian generic manufacturers to accelerate the availability of the drug in more than 100 low- and middle-income countries (LMIC), following approval or EUA by their respective regulatory bodies.

The arrival of an effective and affordable oral drug has long been awaited in the fight against Covid-19 across the world and more so in LMIC which are yet to receive sufficient quantities of vaccines.

There is also growing concerned about the duration of efficacy of the vaccines and their efficacy against new variants. Many rich countries have started booster doses while many developing countries are still waiting for their first doses.

Krishna Reddy believes that India is in a unique position to supply the needed vaccines to countries awaiting them and also the affordable generic oral Molnupiravir, to derive significant geopolitical mileage.

"Reaching the milestone of one billion vaccine doses, India has exhibited remarkable resilience despite the devastating second wave that was driven by the Delta variant. It has restarted its vaccine exports to other countries. It is in a position to start exports of the new effective oral drug that the world has been eagerly awaiting," he added. (IANS/JB)

Keywords: India, Coronavirus, Medicines, Molnupiravir


Photo by Wikimedia Commons.

Char Dham Yatra resumed on Friday with more than 16,000 devotees resuming the pilgrimage from the Rishikesh camp.

As weather cleared up in Uttarakhand, Char Dham Yatra restored on Friday with more than 16,000 devotees resuming the pilgrimage from the Rishikesh camp.

According to sources, road leading to Badrinath has been repaired and helicopter service has also resumed.

Meanwhile, Uttarakhand Chief Minister Pushkar Singh Dhami visited Dungi village and met families of people who were missing after the landslip incident, and consoled them.

Dhami assured them of all possible assistance. Two people from the village are still reported to be missing.

Pilgrims were seen leaving from Rishikesh Char Dham Bus terminal and Haridwar bus station for the pilgrimage since morning.

As per the state government, various departments -- Devasthanam Board, police are assisting the pilgrims.

Police Chowki Yatra Bus Terminal, Rishikesh, was announcing passenger-information via loudspeaker.

Free RT-PCR tests of pilgrims were being conducted at Rishikesh bus terminal.

Uttarakhand Char Dham Devasthanam Management Board's media in-charge Dr Harish Gaur said pilgrimage was on in Kedarnath, Gangotri and Yamunotri, while for Kedarnath, helicopter service was also available.

Though the weather was cold in all dhams, thankfully there was no rain, he added.

Portals of the temple in Badrinath will close on November 20, Gangotri on November 5, while that of Kedarnath and Yamunotri on November 6.

Uttarakhand floods, triggered by a major downpour from October 17 to 19, have claimed 65 lives so far, 3,500 people have been rescued while 16,000 evacuated to safety.

Seventeen teams of National Disaster Response Force (NDRF), seven teams of State Disaster Response Force (SDRF), 15 companies of Provincial Armed Constabulary (PAC) and 5,000 police personnel have been engaged in rescue and relief operations.

The state has already been provided with Rs 250 crore Disaster Fund which is being used for relief works.

To prevent spread of the diseases, the Central and state governments have decided to send medical teams to the affected areas.

Snapped power lines will be restored at the earliest, the government assured.

The state government said that as soon as alert for heavy rainfall was issued, the Incident Response System was activated at state and district levels, and pilgrims were halted at safer places. (IANS/JB)

Keywords: Uttarakhand, India, Char Dham Yatra, PushkarDhami, Rishikesh.


Photo by Wikimedia Commons.

Naga leaders are adamant in their main demands for a separate Constitution and flag.

The Centre has continued the Naga peace talks with the Isak-Muivah faction of National Socialist Council of Nagalim (NSCN-IM) leaders, but negotiations face roadblocks as the Naga leaders are adamant in their main demands for a separate Constitution and flag.

The sources aware of these developments said that the Centre was hopeful that a successful solution of the six decades-long peace talks would arrive at a logical conclusion, but in the recent statements, Naga leaders have accused the Centre of offering post-solution options.

Sources quoting the stand of Naga leaders said that NSCN's stand was loud and clear that it would not follow the forbidden route to the Naga solution that was linked to foregoing the Naga national flag and Constitution, which is the face of the Naga political struggle and identity.

The Naga leaders have also said that the Centre has been using divisive policy and flattery in the name of finding the Naga political solution when the matters heated up.

When the Centre resumed the peace process in September this year and sent the former special director of the Intelligence Bureau (IB) A.K. Mishra as the Ministry of Home Affairs' emissary to the rebel outfit's chief negotiator and general secretary T. Muivah, he assured him (Muivah) that the peace talks would be initiated under the original framework signed in 2015, a source in the Naga rebel group said.

"Here we are talking about the Naga national flag and Yehzabo (Constitution), the two issues that are holding up the Naga solution under the ongoing Indo-Naga political talks in Delhi.

"The chequered history of the Indo-Naga political issue is clear enough before us, with accords and agreements that were never meant to be implemented in letter and spirit", an important office-bearer of the rebel outfit said while criticizing the governments' stand.

Accusing the Centre, he further accused the Centre of persuading the Naga people again to accept whatever is being offered to hurry up the Naga talks.

On the invitation of the Centre, the senior leaders of the NSCN-IM including T. Muivah arrived in the national capital on October 6 this year to hold another round of talks with the Centre.

Both, the Centre and the Naga leaders had indicated their keenness on resolving this long pending issue by the end of this year in an amicable manner.

Assam Chief Minister Himanta Biswa Sharma, who is also chairman of North East Democratic Alliance (NEDA), and Nagaland Chief Minister Neiphiu Rio had been actively involved in the resumption of the peace talks and taking it forward to a logical conclusion.

Soon after the transfer of Nagaland Governor R.N. Ravi, who was appointed as the Centre's interlocutor for the Naga peace talks on August 29, 2014, to Tamil Nadu, the peace talks resumed on September 20 in Kohima when the Centre representative met the Naga leaders and invited them to visit Delhi for further rounds of peace talks.

The NSCN-IM and the other outfits entered into a ceasefire agreement with the Government of India in 1997 and over 80 rounds of negotiations with the Centre have been held in the past in successive governments. (IANS/JB)

Keywords: Nagaland, India, Constitution, Politics, Flag.